Not yet. Our neuromodulation device is still in the clinical-research phase. We are currently conducting carefully controlled human trials to confirm safety and effectiveness and to meet all regulatory requirements. Until those studies are complete and the relevant authorities clear the technology for market release, it cannot be prescribed or sold.